Peer Reviewed • Open Access • Scientific Publishing ISSN 3150-1249

DOI: 10.67186/joafs.v1.i20261.6

From Experimental Models to Precision Therapeutics: Rethinking Drug Discovery in Otorhinolaryngology

Journal of Otorhinolaryngology, Airway, and Facial Surgery

Abstract

Researchers in otorhinolaryngology are shifting their focus from developing drugs based on empirical evidence to using experimental methods that are more predictive, tissue-specific, and patient-oriented. By delivering medications directly to upper airway epithelial surfaces, researchers can study local toxicity, biological activity, mucosal compatibility, and therapeutic concentration before clinical exposure, making this site ideal for translational pharmacology. As a result, preclinical research now relies heavily on primary human nasal epithelial cultures, fibroblast models, respiratory epithelial systems, and cell lines from head and neck cancers. Increasingly, researchers use these platforms to assess repurposed medications, bioactive substances found in nature, agents that promote regeneration, and molecules with anticancer potential. Models that more accurately mimic human tissue biology, such as organ-on-chip technologies, high-content imaging, air-liquid interface cultures, three-dimensional organoids, patient-derived tumor models, and artificial intelligence-assisted analysis, are expected to drive the next phase. This narrative review examines how otorhinolaryngology drug discovery experiments have changed over the years and suggests a unified translational approach that starts with candidate identification and moves through conventional cellular screening, advanced human-derived models, and, finally, clinical validation. Determining a compound's biological activity is no longer the primary concern; instead, the focus is on the optimal concentration, tissue context, illness phenotype, and, ultimately, the patient who will benefit most. With this structure in place, otorhinolaryngologists may be able to speed up rational therapy development, reduce unnecessary animal use, and ease the shift toward precision medicines.

Authors

Ralph Mösges

Keywords

otorhinolaryngology; drug discovery; translational medicine; nasal epithelial cells; cell culture

Publication Information

Publication Date
16.10.2026
Submission Date
13.10.2026
Accepted Date
14.10.2026
Volume
1
Issue
1
Year
2026
Pages
38-43
Language
English
Status
Published
Views
7
Downloads
0
DOI
10.67186/joafs.v1.i20261.6

Files

Download PDF

Citation and Indexing Information

This information is prepared for academic indexes, citation managers, and social sharing tools.

PDF URL: https://joafs.com/public/galley-download.php?id=36

X Facebook LinkedIn WhatsApp Email